| Stephen Ralph Fransen, MD | |
|
608 Stanton L Young Blvd, Oklahoma City, OK 73104-5014 | |
| (405) 271-1092 | |
| (405) 271-3013 |
| Full Name | Stephen Ralph Fransen |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | 608 Stanton L Young Blvd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750358107 | NPI | - | NPPES |
| 100629800C | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 15686 (Oklahoma) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 15686 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Choctaw Nation Health Services Authority | Talihina, OK | Hospital |
| Claremore Indian Hospital | Claremore, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Choctaw Nation Of Oklahoma | 1759294838 | 204 |
| Pawnee Indian Health Center | 2769470160 | 59 |
News Archive
Hospitals in Massachusetts will reap an annual windfall of $275 million due to a loophole enshrined in the new health care law. Hospitals in most other states will get less money as a result.
Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in an upcoming issue of the Journal of Bone & Joint Surgery, demonstrates that MRI can be used to identify implants that are going to fail before people become symptomatic.
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
Two papers that will appear in the journal Molecular Psychiatry, both receiving advance online release, may help identify gene variants that contribute to the risks of developing obsessive-compulsive disorder (OCD) or Tourette syndrome (TS). Both multi-institutional studies were led by Massachusetts General Hospital (MGH) investigators, and both are the first genome-wide association studies (GWAS) in the largest groups of individuals affected by the conditions.
› Verified 7 days ago
| Entity Name | Choctaw Nation Of Oklahoma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659347623 PECOS PAC ID: 1759294838 Enrollment ID: O20031106000326 |
News Archive
Hospitals in Massachusetts will reap an annual windfall of $275 million due to a loophole enshrined in the new health care law. Hospitals in most other states will get less money as a result.
Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in an upcoming issue of the Journal of Bone & Joint Surgery, demonstrates that MRI can be used to identify implants that are going to fail before people become symptomatic.
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
Two papers that will appear in the journal Molecular Psychiatry, both receiving advance online release, may help identify gene variants that contribute to the risks of developing obsessive-compulsive disorder (OCD) or Tourette syndrome (TS). Both multi-institutional studies were led by Massachusetts General Hospital (MGH) investigators, and both are the first genome-wide association studies (GWAS) in the largest groups of individuals affected by the conditions.
› Verified 7 days ago
| Entity Name | Pawnee Indian Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629174081 PECOS PAC ID: 2769470160 Enrollment ID: O20040504001225 |
News Archive
Hospitals in Massachusetts will reap an annual windfall of $275 million due to a loophole enshrined in the new health care law. Hospitals in most other states will get less money as a result.
Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in an upcoming issue of the Journal of Bone & Joint Surgery, demonstrates that MRI can be used to identify implants that are going to fail before people become symptomatic.
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
Two papers that will appear in the journal Molecular Psychiatry, both receiving advance online release, may help identify gene variants that contribute to the risks of developing obsessive-compulsive disorder (OCD) or Tourette syndrome (TS). Both multi-institutional studies were led by Massachusetts General Hospital (MGH) investigators, and both are the first genome-wide association studies (GWAS) in the largest groups of individuals affected by the conditions.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Ralph Fransen, MD 608 Stanton L Young Blvd, Oklahoma City, OK 73104-5014 Ph: (405) 271-1092 | Stephen Ralph Fransen, MD 608 Stanton L Young Blvd, Oklahoma City, OK 73104-5014 Ph: (405) 271-1092 |
News Archive
Hospitals in Massachusetts will reap an annual windfall of $275 million due to a loophole enshrined in the new health care law. Hospitals in most other states will get less money as a result.
Metal-on-metal hip implants can cause inflammation of the joint lining (synovitis) long before symptoms appear, and magnetic resonance imaging (MRI) can be used to identify this inflammation, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in an upcoming issue of the Journal of Bone & Joint Surgery, demonstrates that MRI can be used to identify implants that are going to fail before people become symptomatic.
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.
Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data relating to Soliris (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 52nd Annual Meeting of the American Society of Hematology (ASH), to be held December 4 - 7, 2010 at the Orange County Convention Center in Orlando.
Two papers that will appear in the journal Molecular Psychiatry, both receiving advance online release, may help identify gene variants that contribute to the risks of developing obsessive-compulsive disorder (OCD) or Tourette syndrome (TS). Both multi-institutional studies were led by Massachusetts General Hospital (MGH) investigators, and both are the first genome-wide association studies (GWAS) in the largest groups of individuals affected by the conditions.
› Verified 7 days ago
Vinay Ashok Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9821 S May Ave Ste C, Oklahoma City, OK 73159 Phone: 405-691-0505 Fax: 405-691-0507 | |
Cynthia A Bradford, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
Jila Noorikolouri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-3013 | |
Dr. Brian Keith Firestone, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-6060 Fax: 405-271-7873 | |
David W Parke Ii, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1092 | |
Gary Waine Wilson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7101 Nw Expressway, Suite 335, Oklahoma City, OK 73132 Phone: 405-722-2020 Fax: 405-516-6126 | |
David W. Jackson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 608 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-1095 |